Interdisciplinary Medication Adherence Program: The Example of a University Community Pharmacy in Switzerland

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2016 Feb 4

PMID 26839879

Citations 24

Authors

Melanie Lelubre

Susan Kamal

Noellie Genre

Jennifer Celio

Severine Gorgerat

Denise Hugentobler Hampai

Aline Bourdin

Jerome Berger

Olivier Bugnon

Marie Schneider

Affiliations

Soon will be listed here.

Abstract

The Community Pharmacy of the Department of Ambulatory Care and Community Medicine (Policlinique Médicale Universitaire, PMU), University of Lausanne, developed and implemented an interdisciplinary medication adherence program. The program aims to support and reinforce medication adherence through a multifactorial and interdisciplinary intervention. Motivational interviewing is combined with medication adherence electronic monitors (MEMS, Aardex MWV) and a report to patient, physician, nurse, and other pharmacists. This program has become a routine activity and was extended for use with all chronic diseases. From 2004 to 2014, there were 819 patient inclusions, and 268 patients were in follow-up in 2014. This paper aims to present the organization and program's context, statistical data, published research, and future perspectives.

Citing Articles

The impact of interprofessional collaboration between pharmacists and community health workers on medication adherence: a systematic review.

Bandiera C, Ng R, Mistry S, Harris E, Harris M, Aslani P Int J Equity Health. 2025; 24(1):58.

PMID: 40022158 PMC: 11869407. DOI: 10.1186/s12939-025-02415-4.

A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial.

Bandiera C, Cardoso E, Locatelli I, Zaman K, Diciolla A, Digklia A PLoS One. 2024; 19(6):e0304573.

PMID: 38848380 PMC: 11161104. DOI: 10.1371/journal.pone.0304573.

The differential impact of a 6- 12-month pharmacist-led interprofessional medication adherence program on medication adherence in patients with diabetic kidney disease: the randomized PANDIA-IRIS study.

Bandiera C, Dotta-Celio J, Locatelli I, Nobre D, Wuerzner G, Pruijm M Front Pharmacol. 2024; 15:1294436.

PMID: 38327981 PMC: 10847300. DOI: 10.3389/fphar.2024.1294436.

Building Interprofessional Collaborative Practices Through a Support Program for Patients With Type 2 Diabetes in Primary Care.

Bawab N, Moullin J, Jotterand S, Rossier C, Schneider M, Perraudin C J Contin Educ Health Prof. 2023; 43(2):77-86.

PMID: 36877813 PMC: 10219666. DOI: 10.1097/CEH.0000000000000466.

Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study.

Bandiera C, Locatelli I, Courlet P, Cardoso E, Zaman K, Stravodimou A Cancers (Basel). 2023; 15(1).

PMID: 36612312 PMC: 9818079. DOI: 10.3390/cancers15010316.

References

Krummenacher I, Cavassini M, Bugnon O, Schneider M . Characteristics of HIV patients referred to a medication adherence program in Switzerland. Int J Clin Pharm. 2012; 34(3):426-31. DOI: 10.1007/s11096-012-9638-y. View

Krummenacher I, Spencer B, Du Pasquier S, Bugnon O, Cavassini M, Schneider M . Qualitative analysis of barriers and facilitators encountered by HIV patients in an ART adherence programme. Int J Clin Pharm. 2014; 36(4):716-24. DOI: 10.1007/s11096-014-9930-0. View

Guignard E, Bugnon O . Pharmaceutical care in community pharmacies: practice and research in Switzerland. Ann Pharmacother. 2006; 40(3):512-7. DOI: 10.1345/aph.1G199. View

Drotar D . Strategies of adherence promotion in the management of pediatric chronic conditions. J Dev Behav Pediatr. 2013; 34(9):716-29. DOI: 10.1097/DBP.0b013e31829f6781. View

Fisher J, Fisher W, Amico K, Harman J . An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychol. 2006; 25(4):462-73. DOI: 10.1037/0278-6133.25.4.462. View

Daeppen J, Fortini C, Bertholet N, Bonvin R, Berney A, Michaud P . Training medical students to conduct motivational interviewing: a randomized controlled trial. Patient Educ Couns. 2012; 87(3):313-8. DOI: 10.1016/j.pec.2011.12.005. View

Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A . Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014; (11):CD000011. PMC: 7263418. DOI: 10.1002/14651858.CD000011.pub4. View

Gertsch A, Michel O, Locatelli I, Bugnon O, Rickenbach M, Cavassini M . Adherence to antiretroviral treatment decreases during postpartum compared to pregnancy: a longitudinal electronic monitoring study. AIDS Patient Care STDS. 2013; 27(4):208-10. PMC: 3624692. DOI: 10.1089/apc.2013.0005. View

Achtari Jeanneret L, Schneider M, Troxler S, Bugnon O, Luthi F . [Therapeutic adherence to oral cancer therapy and interdisciplinary management]. Rev Med Suisse. 2011; 7(296):1154-8, 1160. View

10.

Bugnon O, Hugentobler-Hampai D, Berger J, Schneider M . New roles for community pharmacists in modern health care systems: a challenge for pharmacy education and research. Chimia (Aarau). 2012; 66(5):304-7. DOI: 10.2533/chimia.2012.304. View

11.

Wells K, Thornley T, Boyd M, Boardman H . Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation. Res Social Adm Pharm. 2013; 10(1):58-71. DOI: 10.1016/j.sapharm.2013.03.003. View

12.

Krummenacher I, Cavassini M, Bugnon O, Spirig R, Schneider M . Antiretroviral adherence program in HIV patients: a feasibility study in the Swiss HIV Cohort Study. Pharm World Sci. 2010; 32(6):776-86. DOI: 10.1007/s11096-010-9437-2. View

13.

Ortego C, Huedo-Medina T, Llorca J, Sevilla L, Santos P, Rodriguez E . Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011; 15(7):1381-96. DOI: 10.1007/s10461-011-9942-x. View

14.

Demonceau J, Ruppar T, Kristanto P, Hughes D, Fargher E, Kardas P . Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs. 2013; 73(6):545-62. PMC: 3647098. DOI: 10.1007/s40265-013-0041-3. View

15.

Burnier M, Schneider M, Chiolero A, Stubi C, Brunner H . Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens. 2001; 19(2):335-41. DOI: 10.1097/00004872-200102000-00022. View

16.

Marie-Schneider P, Aslani P . Adherence policy, education and practice - an international perspective. Pharm Pract (Granada). 2014; 8(4):209-12. PMC: 4127057. DOI: 10.4321/s1886-36552010000400001. View

17.

Bugnon O, Buchmann M . [Community pharmacy and general internal medicine are at the same crossroads: some opportunities should be seized]. Rev Med Suisse. 2012; 8(364):2287-8, 2290-1. View

18.

Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W . The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med. 2013; 46(1):81-95. DOI: 10.1007/s12160-013-9486-6. View

19.

Vrijens B, de Geest S, Hughes D, Przemyslaw K, Demonceau J, Ruppar T . A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012; 73(5):691-705. PMC: 3403197. DOI: 10.1111/j.1365-2125.2012.04167.x. View

20.

Krummenacher I, Cavassini M, Bugnon O, Schneider M . An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoring. AIDS Care. 2011; 23(5):550-61. DOI: 10.1080/09540121.2010.525613. View